Theophylline
NDC 62332-026, Theophylline, tablet, extended release, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-026
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090430
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62332-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS450 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-026-30 | 62332002630 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-30) |
| 62332-026-31 | 62332002631 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-31) |
| 62332-026-71 | 62332002671 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-71) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/77e849b8-900b-4f0d-ac5c-1391abcd5721NADAC price for package 62332002631
GET /v1/drugs/nadac/62332002631
Use it
Look up 62332-026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.